Direkt zum Inhalt
Merck
  • Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo.

Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo.

Cardiovascular diabetology (2014-12-17)
Carol T Bussey, Anne E de Leeuw, Regis R Lamberts
ZUSAMMENFASSUNG

Increasing numbers of type 2 diabetic and obese patients with enhanced rates of cardiovascular complications require surgical interventions, however they have a higher incidence of perioperative haemodynamic complications, which has been linked to adrenergic dysfunction. Therefore, we aimed to determine how α- and β-adrenoceptor (AR)-mediated haemodynamic responses are affected by isoflurane anaesthesia in experimental type 2 diabetes and obesity in vivo. Sixteen-week old male Zucker type 2 Diabetic Fatty (ZDF) rats, Zucker Obese rats and their lean counterparts (n = 7-9 per group) were instrumented with radio telemeters to record blood pressure and heart rate and with vascular access ports for non-invasive intravenous drug delivery in vivo. Haemodynamic effects of α-AR (phenylephrine; 1-100 μg x kg(-1)) or β-AR (dobutamine; 2-120 μg x kg(-1)) stimulation were assessed under conscious and anaesthetised (isoflurane; 2%) conditions. Vascular α-AR sensitivity was increased in both diabetic (non-diabetic 80 ± 3 vs. diabetic 95 ± 4 ΔmmHg at 100 μg x kg(-1); p < 0.05) and obese (lean 65 ± 6 vs. obese 84 ± 6 ΔmmHg at 20 μg x kg(-1); p < 0.05) conscious rats. Interestingly, anaesthesia exacerbated and prolonged the increased α-AR function in both diabetic and obese animals (non-diabetic 51 ± 1 vs. diabetic 68 ± 4 ΔmmHg, lean 61 ± 5 vs. obese 84 ± 2 ΔmmHg at 20 μg x kg(-1); p < 0.05). Meanwhile, β-AR chronotropic sensitivity was reduced in conscious diabetic and obese rats (non-diabetic 58 ± 7 vs. diabetic 27 ± 8 Δbpm, lean 103 ± 12 vs. obese 61 ± 9 Δbpm at 15 μg x kg(-1); p < 0.05). Anaesthesia normalised chronotropic β-AR responses, via either a limited reduction in obese (lean 51 ± 3 vs. obese 66 ± 5 Δbpm; NS at 15 μg x kg(-1)) or increased responses in diabetic animals (non-diabetic 49 ± 8 vs. diabetic 63 ± 8 Δbpm, at 15 μg x kg(-1); NS at 15 μg x kg(-1)). Long term metabolic stress, such as during type 2 diabetes and obesity, alters α- and β-AR function, its dynamics and the interaction with isoflurane anaesthesia. During anaesthesia, enhanced α-AR sensitivity and normalised β-AR function may impair cardiovascular function in experimental type 2 diabetes and obesity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumchlorid, for molecular biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
Natriumchlorid -Lösung, 5 M in H2O, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
Natriumchlorid -Lösung, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
Natriumchlorid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
SAFC
Natriumchlorid -Lösung, 5 M
Sigma-Aldrich
Lidocain, powder
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Natriumchlorid -Lösung, BioUltra, for molecular biology, ~5 M in H2O
Sigma-Aldrich
Natriumchlorid, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
Natriumchlorid, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
USP
Lidocain, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Lidocain, analytical standard
Sigma-Aldrich
Natriumchlorid-35Cl, 99 atom % 35Cl
Supelco
Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Lidocain, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Natriumchlorid -Lösung, 0.85%
Supelco
Natriumchlorid, reference material for titrimetry, certified by BAM, >99.5%
USP
Trimethoprim, United States Pharmacopeia (USP) Reference Standard
Supelco
Trimethoprim, VETRANAL®, analytical standard
Sigma-Aldrich
Natriumchlorid, tested according to Ph. Eur.
Supelco
Carprofen, Pharmaceutical Secondary Standard; Certified Reference Material
Lidocain, European Pharmacopoeia (EP) Reference Standard
Supelco
Carprofen, VETRANAL®, analytical standard
Trimethoprim, European Pharmacopoeia (EP) Reference Standard
Trimethoprim für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Prilocain, European Pharmacopoeia (EP) Reference Standard
Carprofen für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Carprofen for veterinary use, European Pharmacopoeia (EP) Reference Standard